Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Precision Neoadjuvant Therapy for High Risk Localized Prostate Cancer With PTEN Loss

NCT05593497 is registered in ClinicalTrials.gov with VA Office of Research and Development as lead sponsor.

NCT NCT05593497
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05593497 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Precision Neoadjuvant Therapy for High Risk Localized Prostate Cancer With PTEN Loss
Lead sponsor
VA Office of Research and Development
Phase
Phase 2
Overall status
Recruiting
Start date
May 31, 2024
Completion date
August 1, 2027
Enrollment
30 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

high-risk prostate cancer